Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
Friday
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health | FMCG | Executive
         
Latest Jobs
Exclusive vacancies may not be shown here, please contact Phil on +44 1494 818008 or phil@zenopa.com for more information.
Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Phil Hardy
Account Manager
phil@zenopa.com
+44 1494 818008

Testimonials
I have a lot of experience as a Regional Business Manager, and have been involved in recruitment for the last twenty years or so, therefore, I pride myself in knowing who are the good recruiters.
Jeff, 2012

Karl Storz highlights success and benefits of OR1 Neo

6 September 2012 16:27 in Medical Company Product News


Karl Storz has underlined the benefits offered by its OR1 Neo operating theatre, which have helped the product to claim a market-leading position in the UK.

Currently, the OR1 Neo has a market share of more than 50 percent and has been installed in some of the country's leading hospitals, including the Chelsea and Westminster Hospital and St Mary's Hospital in Paddington.

According to Karl Storz, this is because the operating theatre is fully integrated and incorporates a wide range of equipment and technology to facilitate minimal access endoscopic surgery.

This allows clinicians to benefit from an operating theatre environment in which the latest advances in technology can be seamlessly incorporated into the system.

The manufacturer said: "It combines streamlined, sleek, aesthetic perfection with safety, practicality and unparalleled functionality, creating an environment where surgery of the highest standard can be carried out."

Karl Storz introduced its OR1 product range in 1993 and is constantly working to bring greater efficiency and ergonomic design to operating theatres.ADNFCR-8000103-ID-801444076-ADNFCR

Other news stories from 06/09/2012

Related news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Adfero News Agency



   
© Copyright 2013 Zenopa Ltd